Allspring Global Investments Holdings LLC Boosts Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Allspring Global Investments Holdings LLC lifted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 6,525,926.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,500,986 shares of the company's stock after purchasing an additional 1,500,963 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.91% of Option Care Health worth $52,459,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of OPCH. JPMorgan Chase & Co. boosted its stake in shares of Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after purchasing an additional 344,875 shares in the last quarter. MetLife Investment Management LLC boosted its position in Option Care Health by 7.8% during the fourth quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after buying an additional 14,311 shares during the period. Oppenheimer Asset Management Inc. boosted its position in Option Care Health by 33.0% during the first quarter. Oppenheimer Asset Management Inc. now owns 49,132 shares of the company's stock valued at $1,717,000 after buying an additional 12,180 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its holdings in shares of Option Care Health by 2.7% in the first quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after buying an additional 525 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Trading Down 3.1%

Shares of Option Care Health stock traded down $0.96 during midday trading on Thursday, reaching $30.07. 668,228 shares of the company's stock traded hands, compared to its average volume of 1,863,179. The stock has a 50 day moving average of $32.07 and a 200-day moving average of $31.00. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a market cap of $4.92 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 1.93 and a beta of 0.73. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. Option Care Health's quarterly revenue was up 16.3% compared to the same quarter last year. During the same period last year, the business posted $0.26 earnings per share. As a group, equities analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analyst Ratings Changes

OPCH has been the topic of several recent research reports. JMP Securities restated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research report on Wednesday, June 18th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. Finally, JPMorgan Chase & Co. increased their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.